Coimbra tests therapy for Machado-Joseph disease
ScienceCoimbra

Coimbra tests therapy for Machado-Joseph disease

SAPO Notícias3 September 2026 at 12:07

The city of Coimbra is testing a therapy for Machado-Joseph disease, a pathology that affects the brain and motor abilities of patients. This neurodegenerative disease has been the subject of investigation by local scientists who are looking for new forms of treatment.

The researchers involved in the project state they are "increasingly closer" to developing a safe therapeutic strategy for this condition. The work aims to find an approach that can help improve the quality of life of patients affected by this disease.

The testing of the therapy represents an important milestone in neurological research in Portugal, demonstrating the commitment of Coimbra's scientific community to advancing the study of diseases of the nervous system. The expected results may open new perspectives for the treatment of Machado-Joseph disease.

Related articles

Science

Vaccination against syncytial virus starts on the 16th

The seasonal pediatric vaccination campaign against respiratory syncytial virus starts on the 16th and runs until March 31, 2027. The Directorate-General for Health expects all babies to be eligible for this seasonal RSV vaccination.

Observador03/09/26, 13:32
Comienza el ensayo en humanos de terapia génica nacida en España frente al alzhéimer: mejora la memoria y la neuroinflamación
Science

Human trial begins for Spanish-born gene therapy against Alzheimer's: improves memory and neuroinflammation

A promising gene therapy against moderate Alzheimer's, developed over 14 years ago at the Cajal Institute of the CSIC in Madrid, is set to begin human testing in Australia. The biotech company Tetraneuron received authorization from Australian health authorities to initiate the first clinical study of the TET-101 therapy, which will be conducted at St Vincent's Hospital in Melbourne. Pre-clinical trials demonstrated improvements in memory and neuroinflammation.

El Periódico Mediterráneo - General03/09/26, 13:25
Science

EU allocates €705 million to 421 young researchers, one with a project at Nova in Lisbon

The European Research Council allocated €705 million to 421 early-career researchers through funding grants, an investment aimed at supporting innovative projects in various fields of knowledge. Among the recipients is a researcher with a project to be developed at Universidade Nova de Lisboa, reinforcing Portugal's position in the European scientific landscape. The European Commission announced this allocation as part of the Horizon Europe programme.

Açoriano Oriental03/09/26, 13:10
FIGUEIRA DE CASTELO RODRIGO: Plataforma de Ciência Aberta promove verão com atividades gratuitas ligadas à natureza e à ciência
Science

FIGUEIRA DE CASTELO RODRIGO: Open Science Platform promotes summer with free activities linked to nature and science

The Open Science Platform of Figueira de Castelo Rodrigo prepared a summer program with free activities that aim to bring the population closer to nature and the region's science. The program includes twilight walks at Faia Brava and guided visits to the rock engravings of the Côa Valley, experiences intended for participants of different ages.

SAPO Notícias03/09/26, 13:03